On Nov 2, 2021 Dunad Therapeutics closed a Series A round and raised $24,000,000 from BioGeneration Ventures, Epidarex Capital, Novartis, featuring lead investors BioGeneration Ventures.
About the company: Dunad Therapeutics is located at United Kingdom, Europe.
“”
Company website: http://www.dunad.co.uk